Should I Buy SHPH? SHPH 2026 Analysis

Should You Buy Shuttle Pharmaceuticals Holdings Inc (SHPH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

2.230

1 Day change

2.06%

52 Week Range

20.700

Analysis Updated At

2026/01/26

Shuttle Pharmaceuticals Holdings Inc (SHPH) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with significant losses and no revenue growth. While there is some positive news regarding its oncology pipeline and AI-based drug discovery platform, the stock's high volatility and lack of clear trading signals make it unsuitable for a long-term, risk-averse investor.

Technical Analysis

The MACD is positive and expanding, indicating a potential upward momentum. However, the RSI is neutral, and moving averages are converging, suggesting no strong directional trend. The stock is trading below the pivot level of 2.525, with key support at 1.322 and resistance at 3.729. Pre-market price is down 5.20%, which could indicate bearish sentiment.

Options Data

Positive Catalysts

Recent regulatory approval for AI-based prescriptions in Utah highlights the potential of Shuttle's Molecule.ai platform. The oncology pipeline, including investigational candidates like Ropidoxuridine and SP-2, has attracted strong investor interest, as evidenced by the recent 158% surge in share price.

Neutral/Negative Catalysts

Pre-market price is down 5.20%, and the stock has a 60% chance of declining further over the next week and month. Financial performance is weak, with significant losses and no revenue growth.

Financial Performance

In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -$2,347,302 (down 37.97% YoY), and a significant drop in EPS to -1.05 (down 97.35% YoY). Gross margin remains at 0, indicating no profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

Analyst Rating

Wall Street analysts forecast SHPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SHPH is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 2.180

Low

Averages

High